Al Wang
Albert Wang is Executive Director of Research IT Emerging Methods & Technologies at Bristol Myers Squibb. In this role, he is responsible for accelerating biomedical research through the exploration and adoption of foundational machine learning approaches and related technologies. He has 20+ years of experience in designing and building information systems for accelerating all phases of drug research & development, from early target identification to biomarker discovery to post-launch medical research. He has a Bachelor’s degree in Biomedical Engineering and a Masters degree in Bioinformatics from the University of Pennsylvania.